Table 3: Conditional risk model evaluating the effect of covariates on time to recovery.
|
Patient characteristics |
Hazard Ratio |
P-value |
[95% Confidence Interval] |
|
|
Start regimen |
||||
|
TDF + 3TC + EFV |
Ref |
|||
|
TDF + 3TC + LVP\r |
0.9 |
0.719 |
0.52 |
1.58 |
|
TDF + 3TC + NVP |
0.89 |
0.343 |
0.7 |
1.13 |
|
Gender |
||||
|
Female |
Ref |
|||
|
Male |
0.68 |
0.013 |
0.51 |
0.92 |
|
Age group |
||||
|
Pediatric |
Ref |
|||
|
Adult |
0.66 |
0.029 |
0.46 |
0.96 |
|
CD4 count |
||||
|
Low |
Ref |
|||
|
Normal |
0.91 |
0.421 |
0.72 |
1.14 |
|
Hemoglobin level |
||||
|
Low |
Ref |
|||
|
Normal |
0.78 |
0.054 |
0.61 |
1 |
|
ALT/GPT levels |
1.01 |
0.044 |
1 |
1.01 |
|
Viral Load |
||||
|
Undetectable VL |
Ref |
|||
|
< 1000 copies |
0.91 |
0.654 |
0.6 |
1.37 |
|
> 1000 copies |
1.08 |
0.601 |
0.81 |
1.42 |